NewGenIvf Group (NASDAQ:NIVF) Posts Earnings Results

NewGenIvf Group (NASDAQ:NIVF) issued its earnings results on Wednesday. The company reported ($13.32) EPS for the quarter, missing the consensus estimate of $18.18 by ($31.50), FiscalAI reports. The firm had revenue of $0.96 million for the quarter, compared to the consensus estimate of $20.10 million.

NewGenIvf Group Price Performance

NewGenIvf Group stock opened at $0.08 on Friday. The business’s fifty day moving average is $1.12 and its two-hundred day moving average is $6.93. NewGenIvf Group has a 52 week low of $0.06 and a 52 week high of $1,539.00.

Shares of NewGenIvf Group are scheduled to reverse split on Monday, October 12th. The 1-4 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, October 11th.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Wall Street Zen raised shares of NewGenIvf Group to a “hold” rating in a report on Saturday, July 4th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, July 24th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, NewGenIvf Group presently has a consensus rating of “Sell”.

Insider Activity

In related news, Director Kong Yiu Cheung purchased 2,500,000 shares of NewGenIvf Group stock in a transaction that occurred on Monday, July 27th. The shares were acquired at an average price of $1.00 per share, for a total transaction of $2,500,000.00. Following the transaction, the director directly owned 3,722,223 shares in the company, valued at approximately $3,722,223. This represents a 204.55% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 31.80% of the stock is owned by corporate insiders.

NewGenIvf Group Company Profile

NewGenIvf Group Limited is a fertility-services company that provides assisted reproductive and related medical services. Through its NewGen IVF network, the company serves individuals and couples seeking fertility evaluation, in vitro fertilization (IVF), and other treatments designed to support conception.

Its services include fertility consultations and diagnostic testing, ovarian stimulation, egg retrieval, embryo transfer, intracytoplasmic sperm injection (ICSI), embryo and reproductive-cell freezing, and preimplantation genetic testing.